Indaptus Corp - INDP Net Assets per Single Share

Graphic logo of Indaptus Therapeutics (INDP)

Investments in Indaptus Therapeutics (INDP) research and development remain independent of market cycles and inflationary shocks. The net asset value per common share reflects current capital, where the 0.09 metric serves as the target level. Future revenue is based on the implementation of cancer immunotherapy. The company currently relies on unique bacterial vectors under strict FDA supervision, awaiting drug approval to begin commercialization.

Indaptus Therapeutics Inc (INDP): Share Book Value from 07/04/2022 to 10/27/2026

indaptusrx.com - analytical breakdowns and key metrics (INDP)

- price and consensus price forecast:
Stock Price Indaptus|INDP - Broker Consensus Forecast
- market capitalization data:
Market Value Indaptus Therapeutics, Inc.|INDP - Full Business Value
- book capitalization data:
Net Assets per Single Share Indaptus Therapeutics|INDP - Net Asset Value|Market Capitalization to Book Value Ratio indaptusrx.com|INDP - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Indaptus Therapeutics|INDP - Long-Term Debt to Capital|Short-Term Debt to Equity Indaptus Therapeutics, Inc.|INDP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Indaptus Therapeutics, Inc.
Fundamental company valuation:Indaptus - INDP
Manufactured products of Indaptus Therapeutics, Inc.

Indaptus Therapeutics (INDP) is advancing high-risk developments in the field of immuno-oncology, where business sustainability depends directly on liquidity availability. This metric is calculated as the difference between all assets and liabilities divided by the number of shares, allowing the net asset value per common share to assess the real value of capital and the risk of resource impairment during the platform's early stages.

Competitors of Indaptus Therapeutics (INDP)

Argenx (ARGX) - Book Value per Share|BNTX: Equity per Share|Net Assets per Single Share Abivax Corp (ABVX)|ADMA (admabiologics.com) - Share Book Value|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Book Value per Share ATXS (Astria Pharma)|ENGN: Net Assets per Share|Net Assets per Single Share RAPT Therapeutics, Inc.|Aerovate Therapeutics (JBIO) - Equity per Share|Book Value per Share Aclaris Therapeutics, Inc. (ACRS)|Equity per Share Kyverna Therapeutics Inc.|Book Value per Share TLSA|Book Value per Share CABA (Cabaletta Bio Inc)|Ventyx Biosciences (VTYX) - Net Assets per Single Share|THTX - Share Book Value|Accounting Value per Share Avalo Therapeutics AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Book Price of a Share|AGEN: Accounting Value per Share|CLYM (Climb Bio, Inc) - Book Value per Share|ZURA: Net Assets per Single Share|Net Assets per Share atyrpharma.com (ATYR)|Adagene (ADAG) - Accounting Value per Share|Accounting Value of a Share ikenaoncology.com IMA|Accounting Value per Share Shattuck Labs (STTK)|Book Price of a Share Equillium Inc EQ|Book Value per Share Connect Pharma (CNTB)|IMUX - Accounting Value of a Share|Book Value per Share ATRA|IFRX (InflaRx) - Net Asset Value per Share|XFOR - Net Assets per Single Share|Accounting Value of a Share Adicet|Book Value per Share CELU|Book Value per Share INMB (inmunebio.com)|Barinthus Biotherapeutics plc (BRNS) - Net Assets per Single Share|Share Book Value Kezar Life Sciences Inc. KZR|SABS (SAB Biotherapeutics, Inc) - Book Value per Share|Akari Therapeutics, Plc (AKTX) - Net Asset Value per Share|ENLV: Accounting Value per Share|Book Value per Share Q32 Bio|GeoVax (GOVX) - Accounting Value per Share|Book Price of a Share Edesa Biotech Inc|IBIO (iBio Corp) - Book Value per Share|Net Assets per Share carismatx.com (CARM)|XTL Biopharmaceuticals - Book Value per Share|Bolt Biotherapeutics Inc. - Accounting Value per Share|Net Assets per Single Share HCWB (HCW Biologics Inc)|APVO - Net Assets per Share|AIM ImmunoTech - Book Value per Share|ADTX (Aditxt, Inc.) - Net Assets per Share|Net Assets per Single Share GRI Bio, Inc. (GRI)|Equity per Share xortx.com|Book Value per Share Vyome Holdings HIND|Equity per Share REVB (Revelation Biosciences Inc)|Scinai (SCNI) - Net Assets per Single Share|CalciMedica Inc - Share Book Value|Net Assets per Single Share Affimed Therapeutics|ALLK - Share Book Value|Book Value per Share hookipapharma.com HOOK|IGM Biosciences (IGMS) - Accounting Value of a Share|ITOS (iTeos) - Book Value per Share|Book Value per Share OCEA|TC Biopharm (TCBP) - Net Assets per Single Share|Accounting Value of a Share THRD (thirdharmonicbio.com)